Loading…
Aerosol and Liquid Packaging, Inc. was cited for significant Current Good Manufacturing Practice (CGMP) violations in the manufacturing of over-the-counter drug products, including a topical antiseptic spray, making their finished pharmaceuticals adulterated under federal law. The company failed to conduct required identity testing for drug components and did not validate or establish the reliability of their component suppliers' test analyses at appropriate intervals. Additionally, the firm did not adequately test incoming active pharmaceutical ingredients and other components despite contract manufacturing OTC drug products. The company's unapproved drug product was also found to be introduced into interstate commerce in violation of federal law and was determined to be misbranded.